Sanofi (SNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 122.36B |
| Enterprise value | 132.46B |
| Trailing P/E | 21.45 |
| Forward P/E | 11.93 |
| PEG ratio (5-yr expected) | 0.90 |
| Price/sales (ttm) | 2.50 |
| Price/book (mrq) | 1.56 |
| Enterprise value/revenue | 2.85 |
| Enterprise value/EBITDA | 10.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.45 |
| 52-week change 3 | -8.00% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 55.93 |
| 52-week low 3 | 42.63 |
| 50-day moving average 3 | 47.60 |
| 200-day moving average 3 | 49.99 |
Share statistics
| Avg vol (3-month) 3 | 2.02M |
| Avg vol (10-day) 3 | 2.83M |
| Shares outstanding 5 | 2.5B |
| Implied shares outstanding 6 | 2.53B |
| Float 8 | 1.1B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 9.99% |
| Shares short (15 Apr 2024) 4 | 3.24M |
| Short ratio (15 Apr 2024) 4 | 1.71 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.13% |
| Shares short (prior month 15 Mar 2024) 4 | 4.59M |
Dividends & splits
| Forward annual dividend rate 4 | 2.04 |
| Forward annual dividend yield 4 | 4.13% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 3.72 |
| Payout ratio 4 | 82.36% |
| Dividend date 3 | 06 Jun 2024 |
| Ex-dividend date 4 | 09 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 9.80% |
| Operating margin (ttm) | 18.28% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 46.29B |
| Revenue per share (ttm) | 18.49 |
| Quarterly revenue growth (yoy) | 2.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 12.2B |
| Net income avi to common (ttm) | 4.54B |
| Diluted EPS (ttm) | 2.30 |
| Quarterly earnings growth (yoy) | -43.20% |
Balance sheet
| Total cash (mrq) | 8.71B |
| Total cash per share (mrq) | 6.98 |
| Total debt (mrq) | 18.42B |
| Total debt/equity (mrq) | 24.78% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 59.17 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.